JAZZ News and Press, Jazz Pharmaceuticals plc From 07/20/23

2023-07-20 15:26:42 ET Summary Avadel Pharmaceuticals plc finally won approval of Lumryz™ (sodium oxybate), despite cutthroat opposition from Jazz Pharmaceuticals plc. Potential sales estimate is $3bn. Avadel Pharmaceuticals is flying high, as it well should, but I am a...

2023-06-20 06:39:41 ET Summary Today, we revisit an oncology focused developmental concern called Zymeworks, Inc. The company continues to advance its lead drug candidate, has a huge potential partnership with Jazz Pharmaceuticals and a large cash hoard. The stock has spent mo...

2023-06-08 16:50:50 ET Best Marijuana Stocks To Watch Long Term Do you intend to invest in marijuana stocks in 2023?  Over the last decade, the cannabis industry has grown incredibly, transitioning from a taboo subject to a respectable and wealthy corporate sector. As the globa...

Jazz Pharmaceuticals and Zymeworks Present Positive Pivotal Phase 2b Trial Data at ASCO 2023 Evaluating Zanidatamab in HER2-Amplified Biliary Tract Cancers PR Newswire Results presented today at ASCO 2023 and concurrently published in The Lancet Oncology demonstrate meanin...

2023-05-31 10:45:37 ET FN Media Group Presents USA News Group News Commentary Vancouver, BC – May 31, 2023 – USA News Group –  With this year’s Annual Meeting of the American Society of Clinical Oncology (ASCO 2023) less than 30 days ...

Jazz Pharmaceuticals Demonstrates Continued Leadership in Sleep Medicine with New Data Presentations at SLEEP 2023 PR Newswire Seven abstracts emphasize Jazz's commitment to advancing the care and understanding of debilitating sleep disorders such as narcolepsy and idiopathic ...

Jazz Pharmaceuticals to Participate in the 2023 Goldman Sachs Global Healthcare Conference PR Newswire DUBLIN , May 30, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the 2023 Goldman Sachs Global...

Jazz Pharmaceuticals to Host Zanidatamab KOL Investor Webcast on June 2, 2023 PR Newswire Zanidatamab data to be featured in oral presentation at ASCO 2023 Webcast to follow on June 2, 2023 at 6:45 p.m. CT DUBLIN , May 25, 2023 /PRNewswire/ ...

2023-05-25 07:20:06 ET One investment theme that captured the market’s imagination over the past decade but has been out of favor over recent years and thus might be […] For further details see: Time to Revisit the CBD Growth Theme? (JAZZ, MRES, SNDL, CRON, VFF, YCBD, HEXO...

2023-05-14 23:25:14 ET Summary Seth Klarman’s 13F portfolio value decreased from $6.13B to $5.85B this quarter. Baupost Group increased Alphabet and Fidelity National Information Services while dropping Meta Platforms, Micron Technology, and Amazon.com. The portfolio co...